Who invested in Immunetics?
Immunetics's investors include National Institutes of Health and Massachusetts Life Sciences Center.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$8.1Mraised across 5 rounds since 2011, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $835K sold, first sale Feb 2014
Reported by masshightech.comSEC filing: $629K sold, first sale Aug 2012
No investor was named in the report.
Reported by masshightech.comSEC filing: $629K sold, first sale Aug 2012
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Immunetics's investors include National Institutes of Health and Massachusetts Life Sciences Center.
Immunetics has raised $8.1M across 5 rounds since 2011.
Immunetics's most recent round was a Debt of $835K in Mar 2014.
Immunetics's largest round on record is $3.7M (Grant), in Sept 2012.
Immunetics's first round on record, in May 2011, was backed by Massachusetts Life Sciences Center.
Immunetics's latest named round is a Debt, in Mar 2014.
Immunetics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.